Augmenter of liver regeneration: Mitochondrial function and steatohepatitis
- PMID: 35777586
- DOI: 10.1016/j.jhep.2022.06.019
Augmenter of liver regeneration: Mitochondrial function and steatohepatitis
Abstract
Augmenter of liver regeneration (ALR), a ubiquitous fundamental life protein, is expressed more abundantly in the liver than other organs. Expression of ALR is highest in hepatocytes, which also constitutively secrete it. ALR gene transcription is regulated by NRF2, FOXA2, SP1, HNF4α, EGR-1 and AP1/AP4. ALR's FAD-linked sulfhydryl oxidase activity is essential for protein folding in the mitochondrial intermembrane space. ALR's functions also include cytochrome c reductase and protein Fe/S maturation activities. ALR depletion from hepatocytes leads to increased oxidative stress, impaired ATP synthesis and apoptosis/necrosis. Loss of ALR's functions due to homozygous mutation causes severe mitochondrial defects and congenital progressive multiorgan failure, suggesting that individuals with one functional ALR allele might be susceptible to disorders involving compromised mitochondrial function. Genetic ablation of ALR from hepatocytes induces structural and functional mitochondrial abnormalities, dysregulation of lipid homeostasis and development of steatohepatitis. High-fat diet-fed ALR-deficient mice develop non-alcoholic steatohepatitis (NASH) and fibrosis, while hepatic and serum levels of ALR are lower than normal in human NASH and NASH-cirrhosis. Thus, ALR deficiency may be a critical predisposing factor in the pathogenesis and progression of NASH.
Keywords: Augmenter of liver regeneration; mitochondria; oxidative stress; steatohepatitis; steatosis.
Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Similar articles
-
Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.Hepatology. 2020 Nov;72(5):1586-1604. doi: 10.1002/hep.31167. Epub 2020 Oct 22. Hepatology. 2020. PMID: 32031683 Free PMC article.
-
Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.Gastroenterology. 2015 Feb;148(2):379-391.e4. doi: 10.1053/j.gastro.2014.10.008. Epub 2014 Oct 13. Gastroenterology. 2015. PMID: 25448926 Free PMC article.
-
Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma.Oncogene. 2023 Jan;42(4):308-321. doi: 10.1038/s41388-022-02549-7. Epub 2022 Nov 25. Oncogene. 2023. PMID: 36434180
-
The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease.Front Pharmacol. 2022 Oct 11;13:928606. doi: 10.3389/fphar.2022.928606. eCollection 2022. Front Pharmacol. 2022. PMID: 36304168 Free PMC article. Review.
-
Augmenter of liver regeneration: Essential for growth and beyond.Cytokine Growth Factor Rev. 2019 Feb;45:65-80. doi: 10.1016/j.cytogfr.2018.12.003. Epub 2018 Dec 16. Cytokine Growth Factor Rev. 2019. PMID: 30579845 Review.
Cited by
-
Interleukin-1ß Attenuates Expression of Augmenter of Liver Regeneration (ALR) by Regulating HNF4α Independent of c-Jun.Int J Mol Sci. 2023 Apr 30;24(9):8107. doi: 10.3390/ijms24098107. Int J Mol Sci. 2023. PMID: 37175814 Free PMC article.
-
Impact of liver volumetric regeneration on survival outcomes in patients with hepatocellular carcinoma after major hepatectomy.Langenbecks Arch Surg. 2023 May 13;408(1):193. doi: 10.1007/s00423-023-02908-2. Langenbecks Arch Surg. 2023. PMID: 37178235
-
Comparative Transcriptome Analysis Unveils Regulatory Factors Influencing Fatty Liver Development in Lion-Head Geese under High-Intake Feeding Compared to Normal Feeding.Vet Sci. 2024 Aug 11;11(8):366. doi: 10.3390/vetsci11080366. Vet Sci. 2024. PMID: 39195820 Free PMC article.
-
A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma.J Clin Med. 2023 Feb 6;12(4):1286. doi: 10.3390/jcm12041286. J Clin Med. 2023. PMID: 36835825 Free PMC article.
-
The impact of augmenter of liver regeneration in blunt liver trauma: An experimental model analysis.Ulus Travma Acil Cerrahi Derg. 2024 Jul;30(7):472-479. doi: 10.14744/tjtes.2024.92575. Ulus Travma Acil Cerrahi Derg. 2024. PMID: 38967532 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous